Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serial PSMA PET for Treatment Response Monitoring in Newly Diagnosed Clinically Significant, Treatment-Naïve Prostate Cancer - A Prospective, Multicenter Study

NCT07553780 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT07553780
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07553780 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serial PSMA PET for Treatment Response Monitoring in Newly Diagnosed Clinically Significant, Treatment-Naïve Prostate Cancer - A Prospective, Multicenter Study
Lead sponsor
Xijing Hospital
Phase
Observational
Overall status
Recruiting
Start date
March 7, 2021
Completion date
December 31, 2028
Enrollment
110 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

high-risk prostate cancer, psma pet, therapy monitoring, treatment response